Show
Sort by
-
Genomic biomarkers to guide precision radiotherapy in prostate cancer
-
Validation of a 2-gene mRNA urine test for the detection of >= GG2 prostate cancer in an opportunistic screening population
-
- Journal Article
- A1
- open access
Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients
-
Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer
-
A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection
-
Epigenetic risk score improves prostate cancer risk assessment
-
- Journal Article
- A1
- open access
Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies
-
Urinary prostate protein glycosylation profiling as a diagnostic biomarker for prostate cancer
-
Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer
-
The epigenetic promise for prostate cancer diagnosis.
-
Variations in the exome of the LNCaP prostate cancer cell line
-
Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer